MetaCap

REGENXBIO Insider Trades

NASDAQ: RGNXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.07-0.02 (-0.25%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
2 · $949.38K
Sales
5 · $939.97K
Shares bought / sold
102.60K / 78.93K
Net activity
Net buying $9,411

REGENXBIO insider activity

Over the last 12 months, REGENXBIO insiders reported 39 transactions on SEC Form 4: 2 open-market purchases and 5 sales. Insiders bought $949,381 and sold $939,970 worth of stock, for net insider buying of $9,411. The largest seller was PAKOLA STEVE, with $939,970 in reported sales.

The most recent filing shows Chan Mitchell (Chief Financial Officer) reporting a transaction in 4,902 shares at $9.32 on Sep 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RGNX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

RGNX insider transactions

REGENXBIO insider transactions
DateInsiderTypeSharesValueFiling
Sep 1, 2026Malzahn CraigChief Technology OfficerTax withholding234$2.18KForm 4
Sep 1, 2026Chan MitchellChief Financial OfficerTax withholding4,902$45.69KForm 4
Aug 27, 2026Ciongoli Gregory AustinDirectorBuy53,407$499.68KForm 4
Aug 26, 2026Ciongoli Gregory AustinDirectorBuy49,196$449.71KForm 4
Aug 25, 2026Ciongoli Gregory AustinDirectorAward15,432—Form 4
Aug 1, 2026Christmas Patrick J.Chief Strategy & Legal OfficerTax withholding4,699$45.53KForm 4
Aug 1, 2026PAKOLA STEVEChief Medical OfficerTax withholding7,468$72.36KForm 4
Jul 2, 2026PAKOLA STEVEChief Medical OfficerSale2,161$29.48KForm 4
Jul 2, 2026PAKOLA STEVEChief Medical OfficerOption exercise2,161$16.99KForm 4
Jul 1, 2026PAKOLA STEVEChief Medical OfficerSale36,725$472.28KForm 4
Jul 1, 2026PAKOLA STEVEChief Medical OfficerOption exercise36,725$288.66KForm 4
Jul 1, 2026Simpson CurranChief Executive OfficerTax withholding6,818$89.25KForm 4
Jun 30, 2026Simpson CurranChief Executive OfficerAward1,453$14.79KForm 4
Jun 29, 2026PAKOLA STEVEChief Medical OfficerSale19,608$216.47KForm 4
May 29, 2026Bennett JeanDirectorAward9,807—Form 4
May 29, 2026Fox Allan M.DirectorAward9,807—Form 4
May 29, 2026Glucksmann AlexandraDirectorAward9,807—Form 4
May 29, 2026KARABELAS ARGERIS NDirectorAward9,807—Form 4
May 29, 2026MIGAUSKY GEORGE VDirectorAward9,807—Form 4
May 29, 2026Mills Kenneth T.DirectorAward9,807—Form 4
May 29, 2026Zachary JenniferDirectorAward9,807—Form 4
May 29, 2026Tasse DanielDirectorAward9,807—Form 4
May 29, 2026STUMP DAVID CDirectorAward9,807—Form 4
May 11, 2026PAKOLA STEVEChief Medical OfficerSale15,309$168.71KForm 4
Mar 10, 2026PAKOLA STEVEChief Medical OfficerSale5,124$53.03KForm 4
Feb 1, 2026PAKOLA STEVEChief Medical OfficerTax withholding5,267$58.78KForm 4
Feb 1, 2026Christmas Patrick J.Chief Strategy & Legal OfficerTax withholding4,700$52.45KForm 4
Jan 27, 2026Mills Kenneth T.DirectorTax withholding221,753$2.97MForm 4
Jan 27, 2026Mills Kenneth T.DirectorOption exercise225,000$2.95MForm 4
Jan 6, 2026Christmas Patrick J.Chief Strategy & Legal OfficerAward73,749—Form 4
Jan 6, 2026Simpson CurranChief Executive OfficerAward144,864—Form 4
Jan 6, 2026PAKOLA STEVEChief Medical OfficerAward65,847—Form 4
Jan 6, 2026Chan MitchellChief Financial OfficerAward73,749—Form 4
Jan 6, 2026Malzahn CraigChief Technology OfficerAward65,847—Form 4
Jan 2, 2026Christmas Patrick J.Chief Strategy & Legal OfficerTax withholding9,793$141.02KForm 4
Jan 2, 2026Simpson CurranChief Executive OfficerTax withholding18,559$267.25KForm 4
Jan 2, 2026PAKOLA STEVEChief Medical OfficerTax withholding18,247$262.76KForm 4
Jan 2, 2026Malzahn CraigChief Technology OfficerTax withholding1,238$17.83KForm 4
Dec 31, 2025Simpson CurranChief Executive OfficerAward951$6.65KForm 4
Oct 9, 2025Simpson CurranChief Executive OfficerSale20,811$262.63KForm 4
Sep 29, 2025Simpson CurranChief Executive OfficerSale7,624$76.47KForm 4
Sep 10, 2025Simpson CurranChief Executive OfficerSale7,734$77.49KForm 4
Sep 1, 2025Malzahn CraigChief Technology OfficerTax withholding234$2.09KForm 4
Sep 1, 2025Chan MitchellChief Financial OfficerTax withholding4,901$43.77KForm 4
Aug 1, 2025Christmas Patrick J.Chief Strategy & Legal OfficerTax withholding4,699$38.48KForm 4
Jul 1, 2025Simpson CurranChief Executive OfficerTax withholding4,701$38.69KForm 4
May 30, 2025Zachary JenniferDirectorAward7,768—Form 4
May 30, 2025Fox Allan M.DirectorAward7,768—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related